Literature DB >> 7219005

Laryngeal reconstruction by composite nasal mucoseptal graft after partial laryngectomy. three years follow-up.

N Laurian, Y Zohar.   

Abstract

We have used autogenous nasal mucoseptal (NMS) graft for the reconstruction of the larynx after partial laryngectomy in glottic carcinoma invading the anterior commissure, for the past three years. The composite graft, readily available and obtained without sequela, provides satisfactory and large enough replacement tissue. It provides both a dependable rigid cartilaginous wall and a respiratory mucous lining of the lumen. The method was found to be simple and effective in bridging the laryngeal defect. The free NMS graft was used for reconstruction after extended frontal and frontolateral laryngectomy in 10 patients. The patients were successfully decannulated within 4 to 6 days after the operation and in none of the cases was nasogastric feeding tube or laryngeal stenting necessary. In eight patients anatomical and functional results were achieved; the neolarynx prevented a permanent tracheostomy and a fair voice was obtained.

Entities:  

Mesh:

Year:  1981        PMID: 7219005     DOI: 10.1288/00005537-198104000-00015

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Use of titanium mesh in laryngotracheal reconstruction: an experimental study on rabbits.

Authors:  Murat Yener; Gul Ozbilen Acar; Harun Cansiz; Büge Oz; Engin Cigerciogullari; Oktay Seymen
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-13       Impact factor: 2.503

2.  Design of a new technique using a free tracheal autologous graft for reconstruction of the cricoid cartilage and trachea.

Authors:  Makoto Kobayashi; Akinari Fukuda; Naoya Onozuka; Chiaki Kawagoe; Fuminori Wakayama; Osamu Harada
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Cellular differentiation after free grafting of respiratory epithelia.

Authors:  F Bootz; G Reuter
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.